Edna Efrati

793 total citations
33 papers, 655 citations indexed

About

Edna Efrati is a scholar working on Molecular Biology, Public Health, Environmental and Occupational Health and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Edna Efrati has authored 33 papers receiving a total of 655 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 10 papers in Public Health, Environmental and Occupational Health and 6 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Edna Efrati's work include Acute Lymphoblastic Leukemia research (10 papers), Ion Transport and Channel Regulation (5 papers) and DNA Repair Mechanisms (4 papers). Edna Efrati is often cited by papers focused on Acute Lymphoblastic Leukemia research (10 papers), Ion Transport and Channel Regulation (5 papers) and DNA Repair Mechanisms (4 papers). Edna Efrati collaborates with scholars based in Israel, United States and Germany. Edna Efrati's co-authors include Myron F. Goodman, Georges Tocco, Samuel H. Wilson, Ramón Eritja, Norberto Krivoy, Israel Zelikovic, Eli Sprecher, Jacob M. Rowe, Yehuda Chowers and Tsila Zuckerman and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Neuroscience and Biochemistry.

In The Last Decade

Edna Efrati

33 papers receiving 647 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Edna Efrati Israel 16 384 107 104 104 84 33 655
Branka Zukić Serbia 16 217 0.6× 113 1.1× 79 0.8× 93 0.9× 59 0.7× 56 559
Peter J. Adamson United Kingdom 12 235 0.6× 80 0.7× 52 0.5× 46 0.4× 188 2.2× 16 570
Baili Chen China 15 232 0.6× 85 0.8× 148 1.4× 165 1.6× 66 0.8× 31 685
Shelly Tartakover Matalon Israel 17 159 0.4× 94 0.9× 46 0.4× 47 0.5× 98 1.2× 31 645
Cassie Keener United States 8 154 0.4× 151 1.4× 32 0.3× 53 0.5× 217 2.6× 11 596
Syed Mudassar India 14 232 0.6× 38 0.4× 69 0.7× 50 0.5× 94 1.1× 49 534
Takeshi Takagi Japan 12 437 1.1× 100 0.9× 396 3.8× 38 0.4× 48 0.6× 49 814
Özden Hatırnaz Ng Türkiye 13 270 0.7× 124 1.2× 39 0.4× 44 0.4× 74 0.9× 47 480
Krystyna Gałązka Poland 16 112 0.3× 115 1.1× 33 0.3× 49 0.5× 119 1.4× 68 776
Е. Н. Воронина Russia 15 263 0.7× 33 0.3× 69 0.7× 95 0.9× 71 0.8× 83 634

Countries citing papers authored by Edna Efrati

Since Specialization
Citations

This map shows the geographic impact of Edna Efrati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edna Efrati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edna Efrati more than expected).

Fields of papers citing papers by Edna Efrati

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edna Efrati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edna Efrati. The network helps show where Edna Efrati may publish in the future.

Co-authorship network of co-authors of Edna Efrati

This figure shows the co-authorship network connecting the top 25 collaborators of Edna Efrati. A scholar is included among the top collaborators of Edna Efrati based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edna Efrati. Edna Efrati is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Henig, Israel, et al.. (2021). Decreased Systemic Busulfan Exposure After Oral Dosing With Concomitant Levetiracetam Compared With Phenytoin. Therapeutic Drug Monitoring. 44(3). 414–418. 2 indexed citations
2.
Karban, Amir, et al.. (2016). The association of the MTHFR C677T polymorphism with inflammatory bowel diseases in the Israeli Jewish population. Medicine. 95(51). e5611–e5611. 9 indexed citations
3.
Lev‐Tzion, Raffi, Paul Renbaum, Rachel Beeri, et al.. (2015). Rac1 Polymorphisms and Thiopurine Efficacy in Children With Inflammatory Bowel Disease. Journal of Pediatric Gastroenterology and Nutrition. 61(4). 404–407. 11 indexed citations
4.
Blich, Miry, et al.. (2015). Novel Clinical Manifestation of the Known SCN5A D1790G Mutation. Cardiology. 132(4). 228–232. 7 indexed citations
5.
Azulay‐Debby, Hilla, et al.. (2014). The claudin‐16 channel gene is transcriptionally inhibited by 1,25‐dihydroxyvitamin D. Experimental Physiology. 100(1). 79–94. 12 indexed citations
6.
Hoffer, Erica, et al.. (2014). Comparison of Everolimus QMS Immunoassay on Architect ci4100 and Liquid Chromatography/Mass Spectrometry. Therapeutic Drug Monitoring. 37(2). 214–219. 12 indexed citations
7.
Avivi, Irit, Tsila Zuckerman, Norberto Krivoy, & Edna Efrati. (2013). Genetic polymorphisms predicting methotrexate blood levels and toxicity in adult non-Hodgkin lymphoma. Leukemia & lymphoma. 55(3). 565–570. 22 indexed citations
8.
Koifman, Eduard, Amir Karban, Yoav Mazor, et al.. (2013). Thiopurine Effectiveness in Patients with Crohnʼs Disease. Inflammatory Bowel Diseases. 19(8). 1639–1644. 16 indexed citations
9.
Mazor, Yoav, Eduard Koifman, Yehuda Chowers, et al.. (2013). Risk Factors for Serious Adverse Effects of Thiopurines in Patients with Crohn’s Disease. Current Drug Safety. 8(3). 181–185. 25 indexed citations
10.
11.
Efrati, Edna, et al.. (2012). Population distribution of methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C risk alleles for methotrexate toxicity in Israel. Rheumatology International. 33(4). 1001–1004. 5 indexed citations
12.
Efrati, Edna, et al.. (2011). Transcriptional Regulation of the Pendrin Gene. Cellular Physiology and Biochemistry. 28(3). 385–396. 20 indexed citations
13.
Efrati, Edna, et al.. (2011). Molecular morphometric analysis shows relative intra-tumoural homogeneity for KRAS mutations in colorectal cancer. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 459(5). 487–493. 18 indexed citations
14.
Efrati, Edna, et al.. (2011). LNA-based PCR clamping enrichment assay for the identification of KRAS mutations. Cancer Biomarkers. 8(2). 89–94. 15 indexed citations
15.
16.
Efrati, Edna, et al.. (2010). Transcriptional Regulation of the Claudin-16 Gene by Mg<sup>2+</sup>Availability. Cellular Physiology and Biochemistry. 25(6). 705–714. 12 indexed citations
17.
Elhasid, Ronit, Norberto Krivoy, Jacob M. Rowe, Eli Sprecher, & Edna Efrati. (2010). Glutathione S-transferase T1-null seems to be associated with graft failure in hematopoietic SCT. Bone Marrow Transplantation. 45(12). 1728–1731. 7 indexed citations
18.
Efrati, Edna, et al.. (2008). Molecular mechanisms of epithelial cell-specific expression and regulation of the human anion exchanger (pendrin) gene. American Journal of Physiology-Cell Physiology. 294(5). C1261–C1276. 31 indexed citations
19.
Magen, Daniella, et al.. (2004). Autosomal recessive renal proximal tubulopathy and hypercalciuria: a new syndrome. American Journal of Kidney Diseases. 43(4). 600–606. 7 indexed citations
20.
Efrati, Edna, Georges Tocco, Ramón Eritja, Samuel H. Wilson, & Myron F. Goodman. (1999). “Action-at-a-Distance” Mutagenesis. Journal of Biological Chemistry. 274(22). 15920–15926. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Branka Zukić Breakdown of academic impact, for papers by Peter J. Adamson Breakdown of academic impact, for papers by Baili Chen Breakdown of academic impact, for papers by Shelly Tartakover Matalon Breakdown of academic impact, for papers by Cassie Keener Breakdown of academic impact, for papers by Syed Mudassar Breakdown of academic impact, for papers by Takeshi Takagi Breakdown of academic impact, for papers by Özden Hatırnaz Ng Breakdown of academic impact, for papers by Krystyna Gałązka Breakdown of academic impact, for papers by Е. Н. Воронина
Rankless by CCL
2026